Description
Doctor :
RivoXar Application is a tool to help implement international guidelines into medical practice, it contains highly recommended scores that are related to anticoagulation therapy, it contains Calculators of :
1. CHA2DS2-VASc Score: most commonly utilized method to predict thromboembolic risk in atrial fibrillation.
2. HAS-BLED Score: developed as a practical risk score to estimate the 1-year risk for major bleeding in patients with atrial fibrillation.
3. Other (in Progress).
· The Application is easy to be used, no personal information neither from you or your patients is needed to be able to use The App.
· This guarantees 100% of privacy for you and your patients.
· You can have the Username and Password by contacting Jerusalem Pharmaceutical Company representative.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal (2020) 42, 373_498
• CHA2DS2-VASc Calculator - Figure 12 CHA2DS2-VASc
• HAS-BLED Calculator - Table 10 Clinical risk factors in the HAS-BLED score
ESC 2020 Guidelines for AF Management
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management
This app was developed By Newsoft
www.newsoft.ps
Hide
Show More...
RivoXar Application is a tool to help implement international guidelines into medical practice, it contains highly recommended scores that are related to anticoagulation therapy, it contains Calculators of :
1. CHA2DS2-VASc Score: most commonly utilized method to predict thromboembolic risk in atrial fibrillation.
2. HAS-BLED Score: developed as a practical risk score to estimate the 1-year risk for major bleeding in patients with atrial fibrillation.
3. Other (in Progress).
· The Application is easy to be used, no personal information neither from you or your patients is needed to be able to use The App.
· This guarantees 100% of privacy for you and your patients.
· You can have the Username and Password by contacting Jerusalem Pharmaceutical Company representative.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal (2020) 42, 373_498
• CHA2DS2-VASc Calculator - Figure 12 CHA2DS2-VASc
• HAS-BLED Calculator - Table 10 Clinical risk factors in the HAS-BLED score
ESC 2020 Guidelines for AF Management
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management
This app was developed By Newsoft
www.newsoft.ps
Screenshots
Rivoxar FAQ
-
Is Rivoxar free?
Yes, Rivoxar is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Rivoxar legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Rivoxar cost?
Rivoxar is free.
-
What is Rivoxar revenue?
To get estimated revenue of Rivoxar app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Türkiye yet.
Ratings History
Rivoxar Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Rivoxar Installs
Last 30 days
Rivoxar Revenue
Last 30 daysRivoxar Revenue and Downloads
Gain valuable insights into Rivoxar performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Education
- Publisher
- Jepharm
- Languages
- English
- Recent release
- 2.4.0 (2 years ago )
- Released on
- Jun 15, 2021 (3 years ago )
- Also available in
- United States, Hungary, Taiwan, Türkiye, Saudi Arabia, Poland, New Zealand, Lebanon, South Korea, India, Bulgaria, United Kingdom, Finland, Spain, Egypt, Denmark, Germany, Czechia, Colombia, China
- Last Updated
- 2 hours ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.